A novel IgG-Fc-Fused multiepitope vaccine against Brucella: robust immunogenicity

Brucellosis is one of the most common zoonotic diseases caused by Brucella spp. However, there is currently no Brucella vaccine available for humans. Although some attenuated live vaccines have been approved for animals, their protective efficacy is suboptimal. In previous studies, we utilized an epitope- and structure-based vaccinology platform to identify the immunodominant epitopes of Brucella antigens OMP19, OMP16, OMP25, and L7/L12, and constructed the multi-epitope vaccine MEV-Fc against Brucella. In this study, OMP19, OMP16, OMP25, and L7/L12, and MEV-Fc was expressed and purified via an Escherichia coli expression system, which validated that MEV-Fc possesses high immunological efficacy and exerts a significant protective effect in BALB/c mice within the Brucella infection model. MEV-Fc enhanced Th1 and Th2 immune responses and strongly induced the production of the pro-inflammatory cytokine IFN-γ. Furthermore, MEV-Fc protected mice against Brucella infection compared to control group (PBS). In conclusion, our results provide new insights and data support for the development of human Brucella vaccines.

Authors

Institutions

Publication Details

Journal
Microbial Cell Factories
Published
2025-04-15
DOI
https://doi.org/10.1186/s12934-025-02713-0
Citations
1
Primary Topic
Brucella: diagnosis, epidemiology, treatment
Type
article
Field-Weighted Citation Impact
2.35

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A novel IgG-Fc-Fused multiepitope vaccine against Brucella: robust immunogenicity

Caidong Liu, Xin Yao Li, Songbin Fu, Honghuan Li et al.
1 citations
Microbial Cell Factories
Brucella: diagnosis, epidemiology, treatment
2.35
article

A novel IgG-Fc-Fused multiepitope vaccine against Brucella: robust immunogenicity

Caidong Liu, Xin Yao Li, Songbin Fu, Honghuan Li, Taiping He, Yueli Wang, Kaiat Zhumanov, Zhongchen Ma, Changsuo Zhang, Jihai Yi, Chuang Meng, Yuting Zhang, Wenxiang Zhang, Junbo Zhang, Mingguo Xu, Aodi Wu, Jinliang Sheng, Kexin Yan
article en
1 citations

Abstract

Brucellosis is one of the most common zoonotic diseases caused by Brucella spp. However, there is currently no Brucella vaccine available for humans. Although some attenuated live vaccines have been approved for animals, their protective efficacy is suboptimal. In previous studies, we utilized an epitope- and structure-based vaccinology platform to identify the immunodominant epitopes of Brucella antigens OMP19, OMP16, OMP25, and L7/L12, and constructed the multi-epitope vaccine MEV-Fc against Brucella. In this study, OMP19, OMP16, OMP25, and L7/L12, and MEV-Fc was expressed and purified via an Escherichia coli expression system, which validated that MEV-Fc possesses high immunological efficacy and exerts a significant protective effect in BALB/c mice within the Brucella infection model. MEV-Fc enhanced Th1 and Th2 immune responses and strongly induced the production of the pro-inflammatory cytokine IFN-γ. Furthermore, MEV-Fc protected mice against Brucella infection compared to control group (PBS). In conclusion, our results provide new insights and data support for the development of human Brucella vaccines.

Microbial Cell FactoriesVol. 24(1)
Shihezi University (CN), Kazakh National Agrarian Research University (KZ), Tiandi Science & Technology (China) (CN), Yangzhou University (CN)
National Natural Science Foundation of China, Shihezi University, Department of Education of Guizhou Province
Zero hunger
Openalex Percentile: Top 15%
Brucella: diagnosis, epidemiology, treatment
2.35
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.